Fundraising Fox

David Sourdive

Investor

Venture Partner at Elaia · Chairman of the Board at Hephaistos-Pharma

Greater Paris Metropolitan Region

Find your path to David

91 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.

Christophe JurczakunlockedDavid: together at École Polytechnique (1989)
David: together at Emory University
×2David: together at École Polytechnique
×7David: together at Elaia

About

PhD molecular virologist David Sourdive co-founded Cellectis (1999) and as EVP led technical operations through industrialization and public markets, focusing on Digital Life Sciences as engineerable, data-rich systems.

Invests in

AI & Machine LearningCybersecurityDeep TechHardwareHealthtechSaaS

Chairman of the Board at Hephaistos-Pharma

Intro paths

In turn, David can intro founders to Hephaistos-Pharma's investors below.

Co-founders at Hephaistos-Pharma

MCMartine Caroff
Martine CaroffScientific Founder

Experience

  1. CellectisCo-founder, Executive Vice-President CMC & Manufacturingcurrent2020 — presentVille de Paris, Île-de-France, France
  2. CellectisCo-founder, Executive Vice President, Strategic Initiatives2019 — 2024
  3. CellectisExecutive Vice President Technical Operations2017 — 2024Paris, France
  4. CellectisExecutive Vice President - Corporate Development2008 — 2024
  5. CellectisVice President Business Development2006 — 2008
  6. CellectisChief Operations Officer2000 — 2006
  7. Direction générale de l'armementHead of Biotechnology Laboratory1998 — 2000Centre d'Etudes du Bouchet

Skills & more

Entrepreneurship5Life Science Industry5Biotechnology4Immunology3Molecular Virology2Business Development4Corporate Development4Sciences de la vie1Secteur pharmaceutiqueStratégie1Transfert technologiqueOncologie

From David's professional profile.

Colleagues at Elaia

Frequently asked questions

Who is David Sourdive?
PhD molecular virologist David Sourdive co-founded Cellectis (1999) and as EVP led technical operations through industrialization and public markets, focusing on Digital Life Sciences as engineerable, data-rich systems.
Where does David Sourdive work?
David Sourdive is Venture Partner at Elaia and Chairman of the Board at Hephaistos-Pharma.
What does David Sourdive invest in?
David Sourdive invests in AI & Machine Learning, Cybersecurity, Deep Tech, Hardware, Healthtech, SaaS.
Where did David Sourdive go to school?
David Sourdive studied at Institut Pasteur (Doctor of Philosophy (PhD), Virology); Emory University (Post-Doctoral training, Immunology); École Polytechnique (Bachelor of Science (BS), Physics).

Founder mafias

Same school

Shared employers